Year-over-year earnings per share growth for the last twelve months: Iovance Biotherapeutics (IOVA)

iovance.com (IOVA) - corporate logo

The immuno-oncology industry relies on the independent launch of innovations without mergers. Iovance Biotherapeutics (IOVA) maintains its pioneer status in treating solid tumors by implementing robotic systems for the sterile production of TIL therapies. The shift in quarterly EPS illustrates the earnings per share trend, where 80.60 represents the latest metric reading, helping investors accurately assess asset valuation.

Iovance Biotherapeutics Inc (IOVA) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/16/2026

Comprehensive metric breakdowns and analytics for iovance.com (IOVA)

- share price and expert price forecast:
Comprehensive company analysis:Iovance Biotherapeutics Inc, IOVA
Manufactured product of Iovance Biotherapeutics

The operational achievements of Iovance Biotherapeutics (IOVA) are reflected in the quarterly earnings per share (EPS) dynamics. This indicator measures the rate of change in net income divided by the number of shares, assessing the effectiveness of capital protection against inflation. Growth in this metric confirms the scalability of the business. Outsourcing production and trials allows the company to optimize expenses, directly impacting this figure. Investors should view sharp spikes with caution, avoiding false expectations of infinite growth.

Competitors of Iovance Biotherapeutics

IBRX: Quarterly EPS earnings growth|IMCR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months januxrx.com|Year-over-year net earnings per share growth for the last 12 months arcusbio.com (RCUS)|Year-over-year earnings per share growth for the last twelve months Zymeworks Inc (ZYME)|Year-over-year net earnings per share growth for the last 12 months Tango Pharma TNGX|Immatics NV - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Xencor Inc. XNCR|CMPX - Year-over-year earnings per share growth for the last twelve months|REPL (replimune.com) - Year-over-year earnings per share growth for the last 12 months|Lyell Pharma (LYEL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Innate Pharma, S.A. (IPHA)|Year-over-year net earnings per share growth for the last 12 months PYXS|CGEN - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months IOBT (IO Biotech Corp)|Year-over-year earnings per share growth rate for the last twelve months STRO|Quarterly EPS earnings growth INKT (MiNK Therapeutics)|Year-over-year earnings per one share growth for the last 12 months HOWL|Immix - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months ALX Oncology Holdings Inc.|CUE: Quarterly EPS earnings growth|PDS Biotech - Year-over-year earnings per one share growth for the last 12 months|SONN (Sonnet BioTherapeutics Holdings Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth MAIA Biotech|Year-over-year earnings per share growth for the last twelve months Liminatus Pharma LLC (LIMN)|LVTX: Year-over-year net earnings per share trend for the last twelve months|NextCure Inc - Year-over-year net earnings per share growth for the last 12 months|Leap Therapeutics, Inc. (LPTX) - Earnings per share growth in annualized terms for the last twelve months|Intensity Therapeutics Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months senseibio.com SNSE|TOVX: Quarterly EPS earnings growth|Gritstone bio Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KA|Year-over-year earnings per share growth for the last 12 months NEXI (NexImmune, Inc.)|Year-over-year earnings per share growth for the last twelve months Turnstone Biologics Corporation (TSBX)|Year-over-year net earnings per share growth for the last 12 months Vaccinex VCNX|Year-over-year earnings per share growth for the last twelve months harpoontx.com HARP